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Background: Mycobacterium tuberculosis-specific CD8+ and CD4+ T lymphocyte responses 
restrict the spread of extracellular pathogens by limiting M.tuberculosis replication. Alterations in 
cytolytic function, inappropriate maturation/differentiation, and limited proliferation could reduce 
their ability to control M.tuberculosis replication. 
Methods: In an attempt to further characterize the immune responses during M.tuberculosis 
infection, we enumerated γδ and αβ receptor-bearing T cells expressing CD8 or CD4 phenotype 
and analyzed the differentiation phenotypes of CD8+ and CD4+ T lymphocyte subpopulations in 47 
cases (23 new cases and 24 multidrug resistant patients) and 20 control subjects, using 
flowcytometry.  
Results: We found that the CD4/CD8 ratio was significantly lower in newly-diagnosed 
M.tuberculosis patients compared to multidrug resistant and control subjects (P < 0.003). Also, we 
found that a large proportion of CD8+ T lymphocytes in newly-diagnosed patients was defined by 
increased surface expression of CD57 as compared to the two other settings (P < 0.002). This 
increase was more profound in patients with an inverted CD4/CD8 ratio. Analysis of the late 
activation antigen revealed that this was predominantly HLA-DR+ (P < 0.003). No significant 
changes were observed in the percentages of CD8+CD57+ T cells between the different settings. 
Moreover, the co-stimulatory molecule CD28+ tended to be underexpressed by CD8+ T cells in 
multidrug resistant patients when compared to newly-diagnosed subjects (P < 0.002), but not to the 
control subjects. In contrast, the frequency of CD28+ marker on CD4+ T cells was higher in the 
setting of multidrug resistant compared with those of new cases (P < 0.0001). No significant 
changes were observed in percentages of γδ receptor-bearing T cells between different groups.  
Conclusion: We suggest that the increase in the proportion of CD57+ within CD8+ T cells in 
newly-diagnosed patients results from M.tuberculosis antigenic stimulation, which is a hallmark of 
many infections and that the protracted accumulation of CD57+ T lymphocytes might reflect an 
end-stage differentiation phenotype. 
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Introduction 
 
hagocytosed Mycobacterium tuberculosis 
either replicate within the endocytic 
compartment of mononuclear phagocytes 
or they are destroyed by the host immune cells.1 
Protection against Mycobacterium depends on a 
complex interaction between the host cells and the 
pathogen. Clinical outcomes of pulmonary 
tuberculosis are variable, ranging from 
asymptomatic lifelong infection to parenchymal 
lung destruction, resulting in cavitary lesions. A 
role for gamma/delta receptor-bearing T cells and 
αβ receptor-bearing T lymphocytes expressing 
CD4 or CD8 phenotype in an adaptive immune 
response to infection with M. tuberculosis has been 
suggested by several lines of evidence.2, 3 
Furthermore, several studies of various infections 
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and diseases have indicated that chronic antigenic 
stimulation has been associated with peripheral 
expansion of CD8+ T lymphocytes characterized 
by CD57 expression and down-regulation of CD27 
expression.4, 5 In addition, reports have shown that 
CD8+CD57+ T cells are efficient producers of a 
variety of cytokine.6, 7 In a recent study, it was 
shown that the increased expression of CD57 on 
antigen-specific CD8+ T cells defines replicative 
senescence and antigen-induced apoptotic death of 
CD8+ T lymphocytes.8 Additionally, in the 
presence of decreased levels of CD4 cells, 
elevation of the CD8+CD57+ subpopulation has 
been associated with a combination of preacquired 
immune deficiency syndrome known as AIDS-
related complex (ARC).9, 10 
The CD28 antigen is present on approximately 
60% – 80% of CD3+ T lymphocytes.  Both CD4+ 
and CD8+ T lymphocyte subsets can be separated 
into two functionally distinct subsets based on 
CD28 antigen expression density. These subsets 
differ in their cytotoxic and lymphokine-
production capabilities. For instance, CD4+ 
lymphocytes that express high levels of the CD28 
antigen lack CD3-mediated cytotoxic ability and 
produce only minimal amounts of cytokines. On 
the other hand, CD4+ lymphocytes that express 
low levels of the CD28 antigen possess strong 
CD3-mediated cytotoxicity and produce IL-2, IFN-
γ, and TNF-α/β.11, 12 Expression of the CD28 
antigen also divides the CD8+ lymphocyte subset 
into two functional groups. CD8+CD28+ T 
lymphocytes tend to have long-term proliferative 
capacity in vitro and in vivo, while CD8+CD28- 
lymphocytes are thought to have effector function 
with limited proliferative capacity and shortened 
telomeres.13, 14 Because, CD8+ and CD4+ T cell 
subsets function, differentiation, and maturation 
are critical to immune-mediated control of many 
infections, they are often impaired in many 
infectious diseases.15, 16 Taken together, we, 
therefore, examined the phenotype of the T cell 
subpopulation subsets in the peripheral blood of M. 
tuberculosis patients, with a focus on CD57, co-
stimulatory molecule (CD28), and the late 
activation marker expression within CD8+ T 
lymphocytes. 
 
Materials and Methods 
 
Study population  
The National Research Institute of Tuberculosis 
and Lung Disease Review Board of Research 
Associates approved the use of human subjects for 
this study. We enrolled 47 subjects with pulmonary 
tuberculosis (23 newly diagnosed and 24 multidrug 
resistant [MDR]) and 20 control subjects. 
Screening included history and physical 
examination, complete blood count and 
chemistries, HIV testing, a chest X-ray, and three 
sputum acid-fast bacilli smears. Sputum smear-
positive individuals with symptoms and 
radiographs consistent with pulmonary 
tuberculosis, Karnofsky score > 50%, and without 
prior tuberculosis treatment (in the case of newly-
diagnosed patients) were enrolled. 
 
Sample preparation and flowcytometric 
analysis 
Whole blood samples (2 mL) were obtained by 
venipuncture in a sterile blood collection tube. 
Flowcytometric analysis was performed using a 
FACSCalibur flowcytometry (Becton-Dickinson, 
Mountain View, Ca, USA). Pairs of monoclonal 
antibodies (FITC/PE conjugated), CD45/CD14, 
IgG1/IgG2a, CD3/CD19, CD3/CD4, CD3/CD8, 
CD3/CD16+56, CD3/gamma-delta, CD8/HLA-
DR, CD8+/CD57+, CD8/CD28, and CD4+/CD28+ 
(all from Becton-Dickinson) were used. Twenty 
µL of an appropriate monoclonal antibody were 
mixed with 100 µL of patient’s sample and 
incubated for 20 minutes at room temperature. 
Then 2 mL of BD FACS lysing solution were 
added, followed by centrifugation for 5 minutes. 
The cells were then washed with PBS and 
immediately subjected to flowcytometric analysis 
using Simultest software. 
 
Statistical analysis  
The results were analyzed using Pearson's 
regression model. For each subset of lymphocytes, 
the data were expressed as the mean ± standard 
error of mean (SEM). The reproducibility of each 
subset was determined using Pearson’s correlation 
coefficients. The differences of the mean were 
calculated by the Student's t-test, using SPSS 
analysis with a P value of < 0.05 regarded as 
significant. 
 
Results 
 
Table 1 presents the phenotypic analysis of 
lymphocyte subpopulations, expressed as 
percentages of cells in each of the subpopulations. 
The expression of CD57+ (subset marker), CD57–, 
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CD28+, and HLA-DR within CD8+ were studied. 
Most notably, newly-diagnosed M.tuberculosis 
patients had lower CD4/CD8 ratios and harbored 
significantly higher percentages of CD8+ and 
HLA-DR+ T lymphocytes than the MDR 
M.tuberculosis patients and control subjects (P < 
0.003). Concordantly, significantly greater 
numbers of CD57+ expressing T cells were found 
within peripheral CD8+ T cells than the controls 
and MDR subjects (P < 0.002). This was more 
profound in newly-diagnosed patients with low 
CD4/CD8 ratios. Furthermore, CD28+ was 
expressed by higher percentages of peripheral 
blood CD8+ T lymphocyte subsets in newly-
diagnosed patients than in MDR subjects (P < 
0.003). On the contrary, CD4+ T lymphocytes of 
MDR patients expressed significantly higher levels 
of CD28 antigen as compared to newly-diagnosed 
M.tuberculosis patients (P < 0.0001). No 
significant shift in the relative proportions of CD3, 
CD19, CD16+56 (data not shown), or CD8-CD57+ 
was detectable amongst the different study groups. 
Moreover, no significant differences in the relative 
numbers of γδ receptor-bearing T cells was noticed 
amongst the different study groups. 
 
Discussion 
 
The immune response against infections with 
M. tuberculosis has been studied in vitro and in 
vivo, but the exact mechanisms by which M. 
tuberculosis infections in humans are controlled by 
the cellular immune system are not clearly 
understood.  
The data presented here indicate that, first, 
elevated numbers of CD8+ T lymphocytes were 
observed in the peripheral blood of patients with 
newly-diagnosed Mycobacterium infection when 
compared to MDR and control subjects. Secondly, 
in newly-diagnosed patients, the analysis of their 
late activation antigen (HLA-DR) revealed that 
they were predominantly HLA-DR+. The newly-
diagnosed patients invariably had inverted 
CD4/CD8 ratios. These results are in agreement 
with the reports published previously.17 – 19  
The analysis of phenotypic expansion of CD8+ 
and CD4+ T cells has become a widely used tool 
for studies of immune responses in various 
infectious and pathological conditions.20, 21 In our 
study, flowcytometric immunopheotyping revealed 
significant increases in CD57+ subsets among the 
circulating blood CD8+ T lymphocyte 
subpopulation of untreated M.tuberculosis infected 
patients (newly-diagnosed) when compared to 
MDR and control subjects. This phenomenon 
showed an inverse relationship between the 
percentages of CD8+/CD57+ cells and CD4/CD8 
ratio. While in agreement with several reports, this 
subset has been shown to increase in various 
immunopathological situations such as 
cytomegalovirus infection, HIV infection, alveolar 
echinococcosis, autoimmune diseases, IgA 
deficiency, multiple myeloma, chronic lympho-
cytic leukemia, and pulmonary sarcoidosis. 5, 8, 21 – 
27 These authors concluded that CD57+ T cells 
delineate a subpopulation of CD8+ T cells that 
defines replicative senescence and, hence, antigen-
induced apoptosis of CD8+ T cells. For instance, it 
has been reported that CD57+CD8+ lymphocytes 
are efficient producers of cytokines,7, 15 and that 
they are capable of down-modulating cytotoxic 
activity.28 Further, it has been demonstrated that 
CD57+CD8+ T cells can respond to CMV in vitro 
and exert virus-specific cytotoxicity.23 
Additionally, expansion of CD8+CD28+CD57+ 
has been demonstrated early in CMV infection29 
which, in part, supports our results with newly-
diagnosed M. tuberculosis cases. 
 Lack of CD28 expression on peripheral T 
lymphocytes is an infrequent finding in healthy 
humans as CD28-expressing T cells are able to 
produce a variety of cytokines including IL-2.29 In 
Table 1. Percentages of lymphocyte subpopulation subsets in M.tuberculosis-infected and in control 
subjects (results are expressed as mean ± SEM). 
Lymphocyte population Control Newly diagnosed MDR 
CD3+ 70.62 ± 7.29 74.16 ± 4.89 75.41 ± 3.96 
CD3+/CD4+  42.11 ± 6.95 33.90 ± 4.5 40.33 ± 3.44 
CD3+/CD8+ 28.41 ± 8.58 45.9 ± 5.67 38.5 ± 3.98 
CD4/CD8 1.61 ± 0.6 0.85 ± 0.05 1.37 ± 0.1 
CD3+/γδ-T cell 10.1 ± 2.36 11.9 ± 1.28 13.8 ± 2.19 
CD3+/HLA-DR+ 8.56 ± 2.31 30.81 ± 6.87 14.83 ± 4.58 
CD8+/CD28+ 15.6 ± 1.21 21.8 ± 8.5 13.6 ± 2.65 
CD8+/CD57+ 20.1 ± 2.65 35.1 ± 7.63 14.85 ± 3.2 
CD8-/CD57+ 6.85 ± 2.53 7.0 ± 1.24 6.71 ± 1.39 
CD4+/CD28+ 54.2 ± 1.23 26.36 ± 5.34 51.2 ± 6.5 
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this study, we found that CD28+ was 
underexpressed by MDR patients’ peripheral 
CD8+ T lymphocytes when compared to newly-
diagnosed patients. Conversely, the CD28 antigen 
was overexpressed by MDR patients’ CD4+ T 
cells when compared to newly-diagnosed 
M.tuberculosis patients. Further, it has been 
proposed that the reduced expression of CD28 is 
associated with replicative senescence; a state 
reached by the T lymphocytes after multiple cell 
divisions and characterized by shortened telomeres 
and diminished or altered function.30 A reduced 
expression of CD28, indicating T cell senescence, 
has been reported in the peripheral blood of 
patients with rheumatoid arthritis.31 Our finding of 
a tendency towards reduced expression of CD28 
on CD8 T cells in the peripheral blood of MDR 
patients compared with those of newly-diagnosed 
cases suggests a local Mycobacterium antigen 
stimulation of T cells, leading to generation of 
functionally impaired and/or functionally altered 
end-stage T cells. Moreover, the overexpression of 
the CD28 antigen on peripheral blood CD4+ T 
cells of MDR patients raises a question about 
whether CD4+CD28+ T cell subsets, which do not 
produce macrophage activating cytokines (e.g. 
TNF-α/β, IFN-γ) may not be recruited to the site of 
infection. Therefore, a disturbed antituberculosis 
immune response as a result of skewed 
differentiation, maturation, and/or impaired 
recruitment of functionally active CD8+ and CD4+ 
T lymphocytes may be proposed as a consequence.  
Finally, we found statistically no significant 
differences in the relative proportion of 
gamma/delta receptor-bearing T lymphocytes 
between different study groups, although an 
antiinflammatory role and a high activation status 
for these cells have been suggested during  
M.tuberculosis infection.2, 3, 32, 33 
In conclusion, increases in subpopulation subset 
within either CD4+ or CD8+ in infectious disease 
is a marker of an ongoing or previous immune 
response, but the nature of M. tuberculosis 
antigen(s) driving the evolution of CD57+CD8+ 
and CD4+CD28+ T lymphocytes in the two 
settings is obscure and needs to be investigated. 
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